ABSTRACT NUMBER: ESOC2026A1390 LESS IS MORE: THE NOTCH3-SVD STAGING SYSTEM VERSUS SERUM NEUROFILAMENT LIGHT AS A PREDICTOR FOR DISEASE PROGRESSION IN CADASIL

Gido Gravesteijn, Remco J Hack, Minne N Cerfontaine, Marleen Koel-Simmelink, Charlotte Teunissen, Julie W Rutten, Saskia Lesnik Oberstein · 2026

Read ABSTRACT NUMBER: ESOC2026A1390 LESS IS MORE: THE NOTCH3-SVD STAGING SYSTEM VERSUS SERUM NEUROFILAMENT LIGHT AS A PREDICTOR FOR DISEASE PROGRESSION IN CADASIL by Gido Gravesteijn, Remco J Hack, Minne N Cerfontaine, Marleen Koel-Simmelink, Charlotte Teunissen, Julie W Rutten, Saskia Lesnik Oberstein (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145870.txt.

Description

Gido Gravesteijn and co-authors report a 2026 conference study testing whether a blood marker beats a staging system at forecasting change in CADASIL, an inherited small vessel disease. The staging system sorts patients by routine clinic and scan facts. The blood marker needs costly lab gear.

Fifty-five patients gave blood at the start and again two years on. The blood marker alone did forecast new small strokes and tiny bleeds over the span. Once age entered the checks, its edge shrank. Once stage joined too, the marker lost its signal while stage forecast all three event types. The authors say simple staging should anchor future marker studies in this disease.

Catalog record

CREATORGido Gravesteijn, Remco J Hack, Minne N Cerfontaine, Marleen Koel-Simmelink, Charlotte Teunissen, Julie W Rutten, Saskia Lesnik Oberstein
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13145870

Browse the full library · About the Tower of Babel